Growth Metrics

Oculis Holding AG (OCS) Cash & Equivalents Growth (1y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -68.22%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 988.88%
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 214.58%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 15.64%
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 4.77%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 17.50%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -4.13%
8 Evaxion A 65.12 Bn 65.10 Bn - 3.35%
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 67.78%
10 Oculis Holding AG 24.51 Bn 24.21 Bn - 237.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 237.00%
Dec 31, 2025 221.72%
Sep 30, 2025 31.24%
Jun 30, 2025 83.16%
Mar 31, 2025 -29.82%
Dec 31, 2024 41.80%
Sep 30, 2024 97.48%
Jun 30, 2024 92.60%
Mar 31, 2024 105.27%
Dec 31, 2023 8.61%
Sep 30, 2023 -53.25%
Jun 30, 2023 -54.20%
Dec 31, 2022 -59.08%